{"url_path":"/sec/entx/8-k/2026-07-16/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1638097/0001178913-26-003510-index.html","accession_number":"0001178913-26-003510","cik":"0001638097","ticker":"ENTX","issuer_name":"Entera Bio Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1638097/0001178913-26-003510-index.html","primary_entity_key":"0001638097","primary_entity_name":"Entera Bio Ltd."},"word_count":558,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nThe Company held its 2026 Annual Meeting of Shareholders on July 14, 2026 (the “Annual Meeting”). The final voting results for the proposals submitted to a vote of the Company’s shareholders at the Annual Meeting are as follows:\n\nProposal 1a: Election of Sean Ellis to the Board of Directors of the Company as a Class III director for a three-year term to\nhold office until the Company’s 2029 Annual Meeting of Shareholders:\n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n11,614,671\n\n \n\n402,255\n\n \n\n672\n\n \n\n13,491,120\n\n \n\nProposal 1b: Election of Steven D. Rubin to the Board of Directors of the Company as a Class III director for a three-year\nterm to hold office until the Company’s 2029 Annual Meeting of Shareholders:\n\n \n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n11,126,188\n\n \n\n890,738\n\n \n\n672\n\n \n\n13,491,120\n\n \n\nProposal 1c: Election of Geno H. Germano to the Board of Directors of the Company as a Class III director for a three-year\nterm to hold office until the Company’s 2029 Annual Meeting of Shareholders:\n\n \n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n11,888,019\n\n \n\n128,907\n\n \n\n672\n\n \n\n13,491,120\n\n \n\nProposal 2: Approval of the amended compensation terms for the Company’s non-executive directors, as described in the Proxy\nStatement:\n\n \n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n11,561,138\n\n \n\n323,906\n\n \n\n132,554\n\n \n\n13,491,120\n\n \n\nProposal 3: Approval of share-based compensation, as described in the Proxy Statement, relating to Mr. Steven D. Rubin, a\nDirector of the Company:\n\n \n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n11,386,526\n\n \n\n495,177\n\n \n\n135,895\n\n \n\n13,491,120\n\n \n\nProposal 4: Approval of share-based compensation, as described in the Proxy Statement, relating to Mr. Geno J. Germano, the\nChairman of the Company’s Board of Directors:\n\n \n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n11,439,576\n\n \n\n440,127\n\n \n\n137,895\n\n \n\n13,491,120\n\n \n\nProposal 5: Approval of a one-time grant of compensation, as described in the Proxy Statement, to Mr. Sean Ellis, a Director\nof the Company:\n\n \n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n11,439,213\n\n \n\n440,866\n\n \n\n137,519\n\n \n\n13,491,120\n\n \n\nProposal 6: Approval of a one-time grant of compensation, as described in the Proxy Statement, to Ms. Miranda Toledano, the\nCompany’s Chief Executive Officer and a Director:\n\n \n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n11,413,064\n\n \n\n466,124\n\n \n\n138,410\n\n \n\n13,491,120\n\n \n\nProposal 7: Approval of an amendment to the 2018 Equity Incentive Plan to increase the number of Ordinary Shares issuable\nthereunder by a one-time amount of 2,500,000:\n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n10,824,437\n\n \n\n1,052,206\n\n \n\n140,955\n\n \n\n13,491,120\n\n \n\nProposal 8: Approval of the Articles Amendment to effect an increase in the Company’s authorized share capital:\n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n24,517,240\n\n \n\n837,101\n\n \n\n154,377\n\n \n\n0\n\n \n\nProposal 9: Approval, on an advisory, non-binding basis, of the compensation of the Company’s named executive officers,\nas described in the Proxy Statement:\n\n \n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n11,681,716\n\n \n\n192,384\n\n \n\n143,498\n\n \n\n13,491,120\n\n \n\nProposal 10: Approval of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, an\nindependent registered public accounting firm, as the Company’s independent auditors for the fiscal year ending December 31, 2026, and authorization of the Company’s Board of Directors, or the Audit Committee, if authorized by the\nBoard of Directors, to determine the compensation of the auditors in accordance with the volume and nature of their services, as described in the Proxy Statement:\n\n \n\nVotes\n\n \n\nVotes\n\n \n\n \n\n \n\nBroker\n\nFor\n\n \n\nAgainst\n\n \n\nAbstentions\n\n \n\nNon-Votes\n\n25,469,339\n\n \n\n34,029\n\n \n\n5,350\n\n \n\n0\n\n \n\nNo other matters were considered or voted upon at the Annual Meeting."}